Your browser doesn't support javascript.
loading
The Co-occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results From the National Health and Nutrition Examination Survey.
Egan, Kathryn B; Burnett, Arthur L; McVary, Kevin T; Ni, Xiao; Suh, Minhyung; Wong, David G; Rosen, Raymond C.
Affiliation
  • Egan KB; New England Research Institutes, Inc., Watertown, MA. Electronic address: kegan@neriscience.com.
  • Burnett AL; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD.
  • McVary KT; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL.
  • Ni X; Global Statistical Sciences and Advanced Analytics, Eli Lilly and Company, Indianapolis, IN.
  • Suh M; New England Research Institutes, Inc., Watertown, MA.
  • Wong DG; Eli Lilly and Company USA, Indianapolis, IN.
  • Rosen RC; New England Research Institutes, Inc., Watertown, MA.
Urology ; 86(3): 570-80, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26210004
ABSTRACT

OBJECTIVE:

To establish a descriptive profile of men with coexistent erectile dysfunction (ED) and/or benign prostatic hyperplasia (BPH), ED only or BPH only compared to those with neither condition and to identify the determinants of coexisting disease. MATERIALS AND

METHODS:

Self-report and/or medication use measures defining ED and BPH were assessed in men aged ≥40 years (N = 2142) between 2001 and 2004 using the National Health and Nutrition Examination Surveys. Descriptive analyses examined the ED and/or BPH covariate distribution. Logistic regressions calculated odds ratios (ORs, 95% confidence interval) comparing men with ED and/or BPH, BPH only, or ED only to men with neither condition.

RESULTS:

Of 393 men with BPH, 57.8% had coexistent ED, confirming the moderately strong co-occurrence of the conditions (P <.0001). Coexisting ED and/or BPH occurred in 10.6% of participants, whereas 24.4% and 7.7% reported ED and BPH. After age 60, the odds of reporting ED, BPH, or ED/BPH vs neither almost tripled per decade of increasing age, corresponding to prevalence increases. The unadjusted odds of ED and/or BPH vs no disease increased 1.3 times per prostate-specific antigen unit (ng/mL) increase and 1.1 times per C-reactive protein unit (mg/dL) increase. Other predisposing factors for ED and/or BPH included higher body mass index (OR = 2.5), increased antidiabetic (OR = 2.9) or proton pump inhibitor use (OR = 2.3), increased healthcare visits (≥4; OR = 3.5), and more frequent urinary voiding difficulties (OR = 9.7).

CONCLUSION:

Co-occurring ED and/or BPH is evident in ~10% of men ≥40 years old and is associated with significant clinical correlates. Clinicians need to pay greater attention to this clinically important syndrome in aging men.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Prostatic Hyperplasia / Nutrition Surveys / Erectile Dysfunction Type of study: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Urology Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prostatic Hyperplasia / Nutrition Surveys / Erectile Dysfunction Type of study: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Urology Year: 2015 Type: Article